These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8093682

  • 41. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ, Kaplitt MG, Stern MB, Eidelberg D.
    Hum Gene Ther; 2001 Aug 10; 12(12):1589-91. PubMed ID: 11529246
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.
    Werge T, Elbaek Z, Andersen MB, Lundbaek JA, Rasmussen HB.
    Pharmacogenomics J; 2003 Aug 10; 3(2):97-100. PubMed ID: 12746734
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The Nithsdale Schizophrenia survey: II. Abnormal movements.
    McCreadie RG, Barron ET, Winslow GS.
    Br J Psychiatry; 1982 Jun 10; 140():587-90. PubMed ID: 6125227
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S, Casey DE, Gerlach J, Hetmar O, Kaldan B, Mikkelsen LB.
    Arch Gen Psychiatry; 1982 Sep 10; 39(9):1017-21. PubMed ID: 6126170
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE, Gerlach J, Magelund G, Christensen TR.
    Adv Biochem Psychopharmacol; 1980 Sep 10; 24():577-80. PubMed ID: 6105803
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA, Haugland G, Craig TJ.
    Am J Psychiatry; 1991 Oct 10; 148(10):1322-8. PubMed ID: 1680296
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA, Rexroth K.
    Schizophr Bull; 1980 Oct 10; 6(1):102-16. PubMed ID: 6102788
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.